OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Sabbatini
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute
Palo Alto, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois, United States
- Saint Vincent Oncology Center
Indianapolis, Indiana, United States
- Greater Baltimore Medical Center
Baltimore, Maryland, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- Gynecologic Oncology of West Michigan Pllc
Grand Rapids, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Center of Hope at Renown Medical Center
Reno, Nevada, United States
- the Women'S Institute for Gynecologic Cancer and Special Pelvic Surgery
Phillipsburg, New Jersey, United States
- Southwest Gynecologic Oncology Associates Inc
Albuquerque, New Mexico, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Winthrop University Hospital
Mineola, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Southeast Clinical Oncology Research (scor) Consortium Ncorp
Winston-Salem, North Carolina, United States
- Summa Akron City Hospital/cooper Cancer Center
Akron, Ohio, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Miami Valley Hospital
Dayton, Ohio, United States
- Kettering Medical Center
Kettering, Ohio, United States
- Lake University Ireland Cancer Center
Mentor, Ohio, United States
- University of Toledo
Toledo, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Anmed Health Cancer Center
Anderson, South Carolina, United States
- Greenville Health System Cancer Institute-Eastside
Greenville, South Carolina, United States
- Greenville Health System Cancer Institute-Faris
Greenville, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2010
- Primary completion
- 30 Sept 2015
- Completion
- —
- Last update posted
- 13 Sept 2017
- Registered enrollment
- 171
- Registry id
- NCT00857545
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.